In the interests of helping drug makers prepare for the new legislative climate, database and software provider Cegedim recently organized a seminar.
In the interests of helping drug makers prepare for the new legislative climate, database and software provider Cegedim recently organized a seminar entitled “Is commercial compliance going to be the Achilles heel of the pharmaceutical industry?”. Renowned pharma industry associations directors attended as speakers and delegates coming from the USA, Japan and ten European countries participated.
To receive a copy of the seminar outputs, please send your request to: [email protected]
For more information visit http://www.cegedim-crm.com
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.